SIRT3 and Parkinson disease: Studies have shown that SIRT3 has neuroprotective effects in a mutant α-synuclein rat model of PD, which may be achieved by enhancing mitochondrial bioenergetics and reducing mitochondrial oxidative stress (Gleave et al., 2017).